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Abstract
Background:  In animal studies of the effects of hormonally active agents, measurement of
anogenital distance (AGD) is now routine, and serves as a bioassay of fetal androgen action.
Although measurement of AGD in humans has been discussed in the literature, to our knowledge
it has been measured formally in only two descriptive studies of females. Because AGD has been
an easy-to-measure, sensitive outcome in animals studies, we developed and implemented an
anthropometric protocol for measurement of AGD in human males as well as females.
Methods:  We first evaluated the reliability of the AGD measures in 20 subjects. Then
measurements were taken on an additional 87 newborns (42 females, 45 males). All subjects were
from Morelos, Mexico.
Results: The reliability (Pearson r) of the AGD measure was, for females 0.50, and for males, 0.64.
The between-subject variation in AGD, however, was much greater than the variation due to
measurement error. The AGD measure was about two-fold greater in males (mean, 22 mm) than
in females (mean, 11 mm), and there was little overlap in the distributions for males and females.
Conclusion: The sexual dimorphism of AGD in humans comprises prima facie evidence that this
outcome may respond to in utero exposure to hormonally active agents.
Background
In animal studies of the effects of hormonally active
agents, measurement of anogenital distance (AGD) is
now routine [1-16], and serves as a bioassay of fetal
androgen action. In rodents, perineal growth is dihy-
drotestosterone-dependent [17], males have a greater
AGD than females, and use of AGD to sex newborns is
standard [18]. In animals AGD is correlated at only mod-
est levels with body weight [19], because these measures
reflect the effects of endocrine axes that are largely inde-
pendent. AGD usually tracks through life, varies by dose
of antiandrogen, and can be predictive of other androgen-
responsive outcomes [20].
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Although measurement of AGD in humans has been dis-
cussed in the literature [19,21-23], to our knowledge it
has been measured formally in only two descriptive stud-
ies of females [24,25]. Because AGD has been an easy-to-
measure, sensitive outcome in animal studies, we devel-
oped and implemented an anthropometric protocol for
measurement of AGD in human males as well as females.
This work constitutes a modest step towards evaluation of
AGD in human males as a potentially useful anthropo-
metric measure and indicator of in utero androgen status.
Methods
Subjects
A cross-sectional study was conducted among the new-
born children of women admitted for delivery to the Dr.
Ernesto Meana San Román General Hospital in Jojutla,
Morelos, Mexico, in 1999. This hospital provides medical
care to low socioeconomic status and uninsured popula-
tions. The study included 87 newborn infants, none of
whom had congenital defects or had been admitted to the
neonatal intensive care unit. All infants were born at term
(≥38 weeks gestation), except for one (32 weeks). The
infants were of both sexes and were born after spontane-
ous cephalic delivery or caesarean section. Within 6 hours
of birth, a structured questionnaire about family back-
ground and obstetric history was administered to the
mothers, and anthropometric measurements were taken
on the newborns.
Anthropometry
Anthropometric measurements were taken of weight,
length, head circumference, and AGD. AGD was meas-
ured as follows: the newborn infant was in the dorsal
decubitus position; both hips were flexed and light pres-
sure was exerted on the infant's thighs until the examiner's
hand touched the subject's abdomen. Measurements were
made with Vernier calipers. Distance was measured from
the center of the anus to the posterior convergence of the
fourchette (where the vestibule begins) in female infants
[24]; and from the center of the anus to the junction of the
smooth perineal skin with the rugated skin of the scrotum
in male infants (Figure 1). Gestational age was estimated
according to the Dubowitz scoring system [26].
Reliability
Before any contact with the 87 subjects in the main study,
the personnel performing the anthropometry examined
20 other neonates; all of whom were born after ≥38 weeks
gestation. In this standardization training, 7 female
infants and 13 male infants were measured twice by each
observer. A sufficient time interval (30 minutes) was allot-
ted between each measurement so that the second would
not be influenced by the observer's memory of the first.
These data were used to examine the reliability of meas-
ures and sources of variance.
Statistical analysis
The reliability of the anthropometric measures was calcu-
lated as the Pearson correlation coefficient between the
paired measures. The observations taken by the two
observers were not statistically different when compared
using a paired t-test (results not shown). Analysis of
variance (ANOVA) with a random effect term for subject
was used to estimate between-subject, between-observer,
and within-observer components of variance, by sex.
For the main study, a linear regression analysis was used
to evaluate birth weight, birth length, and gestational age
as predictors of AGD. Age of the mother, number of preg-
nancies, and time elapsed between birth and measure-
ment were not important predictors (or confounders) of
AGD in univariate or multivariate models and were not
considered further in the analysis. To examine influential
values and the overall fit of the model, we conducted an
analysis of residuals, but found nothing of note.
The protocol was approved by human subjects commit-
tees at the National Institute of Public Health in Mexico
and the National Institute of Environmental Health Sci-
ences in the U.S.
Results
Among the 20 subjects in the standardization exercise, the
between-subject coefficient of variation was greater for
measures of AGD in females than for the other measures
(Table 1). The reliability of the AGD measures were lower
than for the traditional measures of anthropometry, with
the female value being slightly lower than that for males.
The variances estimated from the ANOVA were, for
females: between-subjects, 7.9; between-observers, 0.6;
and within-observer, 0.0. For males, the values were:
between-subjects, 3.5; between-observers, 0.0; and
within-observer, 0.1. The relative size of the variance com-
ponents was unchanged when birth weight was included
in the models. Thus, the between-subject variation in
AGD was much greater than the variation due to
measurement error.
Schematic Diagram of Measurements Done, by Sex Figure 1
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Among the 87 subjects in the main study, the birth
weight, length, and head circumference were as expected
in a population from southern Mexico (Table 2) [27]. The
AGD measure was about two-fold greater in males than in
females, and there was little overlap in the distributions
for males and females (Figure 2). The correlation of AGD
with body weight was 0.64 in females and 0.48 in males.
In the crude models of AGD in females, weight, length,
and gestational age all appeared to be predictive (Table 3).
The adjusted results, however, suggested that weight of the
newborn was the most important correlate, based on the
p value being lower than for length or gestational age. For
males, weight and length were more important than ges-
tational age as determinants, and this pattern was seen
also in the adjusted results (Table 4). Length had a slightly
larger R2 and slightly lower p value, suggesting it may be a
marginally better predictor than weight in males. In a
model of data for males that included weight, length, and
gestational age, the p values for both length and gestation
were less than 0.05, although the coefficient for gestation
was negative. In a model of AGD based on data for males
and females combined (results not shown), after adjust-
ment for weight, the term for sex was clearly important (β
for males = 10.9 mm, standard error = 0.4, p < 0.0001;
change in R2 due to addition of sex to model = 0.86).
Discussion
The AGD measures employed in the present study reflect
the location of the caudal border of the genital swelling,
an embryologic structure that differentiates into the labia
majora in females and the scrotum in males. After the
indifferent stage of the external genitalia, the critical
events determining the sexual dimorphism of AGD in
humans begin when, relative to the anus, the genital
swelling, urethral folds, and possibly the genital tubercle,
move ventrally under the influence of androgens [28].
Elongation of the genital tubercle, which becomes the
phallus, also occurs at this time. The difference between
males and females in our data demonstrates sexual dimor-
phism of this particular measure of AGD. The two-fold
difference in the aspect of AGD that we measured is not
reflected in the schematic diagrams of human sexual dif-
ferentiation we have seen [29,30], which is likely due to
the previous lack of formal measures.
Direct comparison of our results with those in the two
other studies with measures of anus-to-fourchette (AF)
distance in female newborns [24,25] is hampered by dif-
ferent eligibility criteria, and possibly different ethnicities,
in the three studies. For example, Callegari et al.'s subjects
had a mean weight of 2,530 g; Phillips et al. did not
present mean birth weight but subjects were required to
have a birth weight above 2,750 g; and in our study the
mean birth weight among females was 3,060 g. The mean
AF distance in the Callegari et al. study was 10.9 mm; in
the Phillips et al. study was 16.1 mm in Jews and 16.5 in
Bedouins, and in the present study was 11 mm. Callegari
reported no ethnic differences in their population (62.6%
Hispanic, 28.7% black, and 8.7% white). Despite the eth-
nic-specific mean values noted above, Phillips et al.
reported that Jewish females had a greater AF distance
than did Bedouins. The similarity of the mean AF distance
measures in the present study and the Callegari et al. study
is surprising given the difference in mean birth weights,
and suggests ethnic differences, or a systematic difference
in how the measurements were done.
Compared with established anthropometric measures on
newborns, the reliability of the AGD measures were lower.
The lower reliability of the AGD measures is likely due to
several factors. The AGD measures depend on indistinct
landmarks on soft tissues. Structures such as "the center of
the anus" or the posterior fourchette are not clearly
demarcated. Any slight traction or pressure applied to the
perineum or surrounding structures could alter measures.
Finally, compared with established anthropometric meas-
ures on newborns, the AGD dimensions are smaller, thus
measures done with the naked eye on a subject unlikely to
hold still are inherently at a disadvantage. Use of two
observers, one to restrain the subject and one to do the
measurements could result in improved reliability com-
pared to our approach, which employed one observer.
Table 1: Mean, coefficient of variation (CV), and reliability of anthropometric measurements in 20 newbornsa
Measurement Mean CV Reliability
Weight (kg) 3.01 0.13 1.00
Length (cm) 48.9 0.03 0.97
Head Circumference (cm) 34.2 0.03 0.98
Anogenital distance 18 0.31 0.91
Female 11 0.27 0.50
Male 21 0.09 0.64
a 7 females and 13 males.Environmental Health: A Global Access Science Source 2004, 3:8 http://www.ehjournal.net/content/3/1/8
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Compared with adult humans, the size of the genitals at
birth is large relative to the body overall [28]. Yet the gen-
ital size is, of course, still determined in part by overall
body dimensions and age. The need to adjust AGD for
overall body dimension is well known in animal experi-
ments [19]. In humans, the best approach to such adjust-
ment remains unclear. Our data suggest that for the aspect
of AGD we measured, adjustment for body weight is
reasonable.
A complete assessment of AGD in humans would include
more measurements than were done in our study. In neo-
natal rodents, measurement of AGD is relatively
straightforward and is the distance from the genital tuber-
cle to the anus. In older animals or humans of any age,
however, questions arise as to which measure is most
informative. For example, in human males, rather than a
genital tubercle, the presence of the phallus and testicles
at birth means that a number of measurements are
possible. The measurement in the present study, from the
posterior scrotal-perineal junction, represents only one
such measurement. Ideally we would have done genital
tubercle measurements in males and females, but we did
not. Whether sexual dimorphism exists in the distance
from the anus to the genital tubule (penile base in males)
would be useful to know. While one might expect that
penile length may be a good measure of androgenization
among males, difficulties obtaining a reliable measure
mean that alternative measures, such as AGD, are worth
investigating.
Effects of endocrinopathies on AGD in humans have been
described, but only to a limited degree. A rare form of con-
genital adrenal hyperplasia that causes incomplete mascu-
line development has been reported to cause decreased
AGD in boys [21]. Details on how the measurement was
done (and the measured values), however, were not pre-
sented [22,23]. Callegari et al. [24] measured the distance
Table 2: Distribution of selected characteristics in 87 newborns, Mexico, 1999a
Variable Female n = 42 Male n = 45
Anogenital distance (mm) Mean 11 21
SD 2 3
Median 11 22
25th percentile 10 20
75th percentile 11 23
Weight (g) Mean 3070 3060
SD 408 440
Median 3060 3110
25th percentile 2870 2800
75th percentile 3310 3290
Length (cm) Mean 48.6 48.7
SD 1.4 2.2
Median 48.6 48.7
25th percentile 47.5 48.0
75th percentile 49.6 49.9
Head circumference (cm) Mean 337 341
SD 10.9 16.7
Median 337 341
25th percentile 330 334
75th percentile 345 350
aSD, standard deviation
Distribution of Anogenital Distance (AGD), by Sex Figure 2
Distribution of Anogenital Distance (AGD), by SexEnvironmental Health: A Global Access Science Source 2004, 3:8 http://www.ehjournal.net/content/3/1/8
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from the anus to the fourchette (same as what we did) and
in addition measured the distance from the anus to the
clitoris; the ratio of these two measures in three newborn
females with congenital adrenal hyperplasia was
increased relative to normal newborn females. Earlier case
reports on females with adrenogenital syndrome noted
labiosacral fusion, but again, no formal measures were
published [23]. The utility of AGD measures in humans is
further supported by experimental data in primates show-
ing that in utero exposure of females to androgenic agents
increased AGD [1].
The purported mechanism by which androgens increase
AGD in females is by inducing "labioscrotal fusion" (in
normal males fusion begins caudally and proceeds ven-
trally, presumably androgens in females act the same way)
[24]. This mechanism, however, does not account for why
males who are not fully androgenized would have a
decreased AGD, unless AGD in males is defined as being
from tip of penis to the center of the anus. A set of formal
AGD measures on subjects with selected congenital endo-
crinopathies or birth defects could be useful in evaluating
whether this outcome is uniformly responsive to gross
stimuli, and may help discern details of normal embryol-
ogy and the consequences of disrupting it.
Conclusions
In summary, we have shown that an aspect of genital
dimension that reflects migration of the genital swelling is
sexually dimorphic in humans. Whether this particular
measure, or other measures of AGD in humans, has any
utility as markers of exposure in utero to hormonally active








Table 3: Regression coefficients for anogenital distance as a function of characteristics at birth, femalesa
Variable Crude Adjustedb
Coefficient 95% CI p value R2 Coefficient 95% CI p value R2
Birth weight 0.002 0.002 0.003 0.000 0.41 0.002c 0.001 0.003 0.000 0.43
Birth length 0.319 -0.005 0.642 0.061 0.09 0.141c -0.189 0.471 0.407 0.22
Gestational age 1.296 0.516 2.076 0.002 0.21 0.501d -0.282 1.283 0.217 0.43
aUnits for regression coefficients are mm of AGD per unit characteristic (g, cm, or weeks). Results based on 42 females. CI, confidence interval.
b Multivariate adjusted regression coefficients (adjustment factors listed below).
c Adjusted for gestational age.
d Adjusted for weight of newborn infant.
Table 4: Regression coefficients for anogenital distance as a function of characteristics at birth, malesa
Variable Crude Adjustedb
Coefficient 95% CI p value R2 Coefficient 95% CI p value R2
Birth weight 0.003 0.001 0.005 0.001 0.23 0.004c 0.002 0.006 0.001 0.27
Birth length 0.671 0.348 0.995 0.000 0.28 0.914c 0.499 1.329 0.000 0.33
Gestational age 0.356 -0.258 0.971 0.262 0.03 -0.560d -1.284 0.165 0.137 0.27
aUnits for regression coefficients are mm of AGD per unit characteristic (g, cm, or weeks). Results based on 45 males. CI, confidence interval.
b Multivariate adjusted regression coefficients (adjustment factors listed below).
c Adjusted for gestational age.
d Adjusted for weight of newborn infant.Environmental Health: A Global Access Science Source 2004, 3:8 http://www.ehjournal.net/content/3/1/8
Page 6 of 6
(page number not for citation purposes)
Authors' contributions
ES participated in the design of the study, carried out the
measurements, and wrote the first draft of the manuscript.
PR participated in the study coordination and data man-
agement. EY carried out and coordinated the measure-
ments. ML originated the idea that AGD measurements in
human males may be useful, revised the manuscript, and
analyzed the data. MH conceived of the study and partic-
ipated in its design and coordination. All authors read and
approved the final manuscript.
Acknowledgements
We are grateful to Alma Gonzalez-Rodriquez, MD, from the Instituto 
Nacional de Salud Publica, Cuernavaca, Mexico, for taking the anthropo-
metric measurements of the infants, to the administrators of Dr. Ernesto 
Meana San Román General Hospital in Jojutla, Morelos, Mexico, for their 
cooperation and support, and to Grace Kissling, PhD, for statistical 
support.
References
1. Hendrickx AG, Korte R, Leuschner F, Neumann BW, Prahalada S,
Poggel A, Binkerd PE, Gunzel P: Embryotoxicity of sex steroidal
hormone combinations in nonhuman primates: I. Norethis-
terone acetate + ethinylestradiol and progesterone + estra-
diol benzoate (Macaca mulatta, Macaca fascicularis, and
Papio cynocephalus). Teratology 1987, 35:119-127.
2. Gray LE Jr, Ostby JS, Kelce WR: Developmental effects of an
environmental antiandrogen: the fungicide vinclozolin alters
sex differentiation of the male rat. Toxicol Appl Pharmaco 1994,
129:46-52.
3. You L, Casanova M, Archibeque-Engle S, Sar M, Fan LQ, Heck HA:
Impaired male sexual development in perinatal Sprague-
Dawley and Long-Evans hooded rats exposed in utero and
lactationally to p,p'-DDE. Toxicol Sci 1998, 45:62-73.
4. Mylchreest E, Sar M, Cattley RC, Foster PM: Disruption of andro-
gen-regulated male reproductive development by di(n-
butyl) phthalate during late gestation in rats is different from
flutamide. Toxicol Appl Pharmacol 1999, 156:81-95.
5. Gray LE Jr, Wolf C, Lambright C, Mann P, Price M, Cooper RL, Ostby
J:  Administration of potentially antiandrogenic pesticides
(procymidone, linuron, iprodione, chlozolinate, p,p'-DDE,
and ketoconazole) and toxic substances (dibutyl- and
diethylhexyl phthalate, PCB 169, and ethane dimethane sul-
phonate) during sexual differentiation produces diverse pro-
files of reproductive malformations in the male rat. Toxicol Ind
Health 1999, 15:94-118.
6. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE Jr: The
fungicide procymidone alters sexual differentiation in the
male rat by acting as an androgen-receptor antagonist in
vivo and in vitro. Toxicol Ind Health 1999, 15:80-93.
7. McIntyre BS, Barlow NJ, Wallace DG, Maness SC, Gaido KW, Foster
PM:  Effects of in utero exposure to linuron on androgen-
dependent reproductive development in the male
Crl:CD(SD)BR rat. Toxicol Appl Pharmacol 2000, 167:87-99.
8. Nagao T, Ohta R, Marumo H, Shindo T, Yoshimura S, Ono H: Effect
of butyl benzyl phthalate in Sprague-Dawley rats after gav-
age administration: a two-generation reproductive study.
Reprod Toxicol 2000, 14:513-532.
9. Fielden MR, Halgren RG, Tashiro CH, Yeo BR, Chittim B, Chou K,
Zacharewski TR: Effects of gestational and lactational expo-
sure to Aroclor 1242 on sperm quality and in vitro fertility in
early adult and middle-aged mice.  Reprod Toxicol 2001,
15:281-292.
10. McIntyre BS, Barlow NJ, Foster PM: Androgen-mediated devel-
opment in male rat offspring exposed to flutamide in utero:
permanence and correlation of early postnatal changes in
anogenital distance and nipple retention with malformations
in androgen-dependent tissues. Toxicol Sci 2001, 62:236-249.
11. Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, Parks L, Veeramach-
aneni DN, Wilson V, Price M, Hotchkiss A, Orlando E, Guillette L:
Effects of environmental antiandrogens on reproductive
development in experimental animals.  Hum Reprod Update
2001, 7:248-264.
12. McIntyre BS, Barlow NJ, Foster PM: Male rats exposed to linuron
in utero exhibit permanent changes in anogenital distance,
nipple retention, and epididymal malformations that result
in subsequent testicular atrophy. Toxicol Sci 2002, 65:62-70.
13. Shimamura M, Kodaira K, Kenichi H, Ishimoto Y, Tamura H, Iguchi T:
Comparison of antiandrogenic activities of vinclozolin and
D,L-camphorquinone in androgen receptor gene transcrip-
tion assay in vitro and mouse in utero exposure assay in vivo.
Toxicology 2002, 174:97-107.
14. Miyata K, Yabushita S, Sukata T, Sano M, Yoshino H, Nakanishi T,
Okuno Y, Matsuo M: Effects of perinatal exposure to flutamide
on sex hormones and androgen-dependent organs in F1
male rats. J Toxicol Sci 2002, 27:19-33.
15. Wang XQ, Fang J, Nunez AA, Clemens LG: Developmental expo-
sure to polychlorinated biphenyls affects sexual behavior of
rats. Physiol Behav 2002, 75:689-696.
16. Turner KJ, Barlow NJ, Struve MF, Wallace DG, Gaido KW, Dorman
DC, Foster PM: Effects of in utero exposure to the organo-
phosphate insecticide fenitrothion on androgen-dependent
reproductive development in the Crl:CD(SD)BR rat. Toxicol
Sci 2002, 68:174-183.
17. Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PM: Effects
of in utero exposure to finasteride on androgen-dependent
reproductive development in the male rat. Toxicol Sci 2003,
74:393-406.
18. Marty MS, Chapin RE, Parks LG, Thorsrud BA: Development and
maturation of the male reproductive system. Birth Defects Res
Part B Dev Reprod Toxicol 2003, 68:125-136.
19. Gallavan RH Jr, Holson JF, Stump DG, Knapp JF, Reynolds VL: Inter-
preting the toxicologic significance of alterations in anogeni-
tal distance: potential for confounding effects of progeny
body weights. Reprod Toxicol 1999, 13:383-390.
20. Gray LE Jr, Ostby J, Monosson E, Kelce WR: Environmental
antiandrogens: low doses of the fungicide vinclozolin alter
sexual differentiation of the male rat. Toxicol Ind Health 1999,
15:48-64.
21. Goldman AS, Bongiovanni AM: Induced genital anomalies. Ann N
Y Acad Sci 1967, 142:755-767.
22. Bongiovanni AM, Root AW: The adrenogenital syndrome. N Engl
J Med 1963, 268:1283-9. 1342–1351
23. Bongiovanni AM, Kellenbenz G: The adrenogenital syndrome
with deficiency of 3β-hydroxysteroid dehydrogenase.  J Clin
Invest 1962, 41:2086-2092.
24. Callegari C, Everett S, Ross M, Brasel JA: Anogenital ratio: meas-
ure of fetal virilization in premature and full-term newborn
infants. J Pediatr 1987, 111:240-243.
25. Phillip M, De Boer C, Pilpel D, Karplus M, Sofer S: Clitoral and
penile sizes of full term newborns in two different ethnic
groups. J Pediatr Endocrinol Metab 1996, 9:175-179.
26. Dubowitz LM, Dubowitz V, Goldberg C: Clinical assessment of
gestational age in the newborn infant. J Pediatr 1970, 77:1-10.
27. Flegal KM, Launer LJ, Graubard BI, Kestler E, Villar J: Modeling
maternal weight and height in studies of pregnancy outcome
among Hispanic women. Am J Clin Nutr 1993, 58:145-151.
28. Langman J: Medical Embryology: Human development – Normal and
Abnormal 3rd edition. Baltimore: The Williams & Wilkins Company;
1975:160-200. 
29. Hannon TS, Fuqua JS: Sexual differentiation. In: Developmental
Endocrinology Edited by: Eugster EA, Pescovitz OH. Totowa, NJ:
Humana Press; 2002:261-291. 
30. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM,
French FS: Androgen receptor defects: historical, clinical, and
molecular perspectives. Endocr Rev 1995, 16:271-321.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1476-069x/3/8/prepub